$LGVN
Longeveron Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Miami, FL
LGVN chart
What traders are saying about $LGVN
Latest postsLongeveron Inc. news
- Form 8K Longeveron LLC For: 26 October By Investing.com
Investing.com Canada ·
- Longeveron reports ELPIS II trial misses primary endpoint
TipRanks ·
- Longeveron Announces Updated Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)
Yahoo Finance ·
- An infant heart trial recorded 8 major events with standard care, 1 with experimental cell therapy. It missed its main goal.
Stock Titan ·
- symbol__ Stock Quote Price and Forecast
CNN ·
- Longeveron Inc. Estimates – NASDAQ:LGVN
TradingView ·
- Longeveron to Participate in Three Longevity/Aging Investment Conferences
Yahoo Finance ·
- Longeveron (LGVN) Heart Treatment Falls Short. Can a Strategic Review Preserve Value?
Yahoo Finance ·
- Ultragenyx prices Sanfilippo gene therapy at $4M; Bristol Myers shelves Orum drug
biopharmadive.com ·
- LGVN Posts Disappointing Trial Results
Yahoo Finance ·
- Longeveron Announces Topline Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)
Yahoo Finance ·
- Longeveron to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Yahoo Finance ·
Longeveron Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $1.2M | $2.4M | $709,000 | – |
| Net income | -$22.7M | -$16.0M | -$21.4M | -$18.8M |
| Diluted EPS | $-1.29 | $-2.62 | $-10.22 | $-0.90 |
| Total assets (year end) | $10.3M | $25.6M | $12.1M | $27.4M |
| Cash and equivalents (year end) | $4.7M | $19.2M | $4.9M | $10.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Longeveron Inc.
- Ticker
- LGVN (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Miami, FL
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1721484
- Former names
- LONGEVERON LLC
Frequently asked questions
What exchange is Longeveron Inc. listed on?
Longeveron Inc. trades on the Nasdaq under the ticker symbol LGVN.
What industry is Longeveron Inc. in?
Longeveron Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Longeveron Inc. headquartered?
Longeveron Inc.'s business address on file with the SEC is in Miami, FL.
When does Longeveron Inc.'s fiscal year end?
Longeveron Inc.'s fiscal year ends on December 31.
How much revenue did Longeveron Inc. report?
Longeveron Inc. reported $1.2M in revenue for calendar year 2025, according to its SEC filings.